Osteoarthritis

Essential Fatty Acids and Osteoarthritis

Arthritis Care Res (Hoboken)Published Nested case-control study

Main finding · Incident symptomatic knee OAResult — go to the resultOdds ratio 1.0 95% CI 0.87–1.17

Authors' conclusion

We found no association of serum levels of EPA or of other specific n-3 fatty acids or n-6 fatty acids with risk of incident knee OA or other OA outcomes.

Study context

Population
Multicenter Osteoarthritis Study (MOST) participants at risk of knee osteoarthritis (OA), without baseline OA; mean age 62 years (59% women)
Comparison
Serum levels of specific n-3 and n-6 fatty acids and incident knee OA
  • Incident symptomatic knee OAn = 363
  • Incident radiographic knee OAn = 295
Outcome
Incident radiographic OA and incident symptomatic knee OA (knee pain and radiographic OA)
Follow-up
60 months
Methodological detailsMulticenter Osteoarthritis Study (MOST), baseline fasting serum samples, adjusted regression models
  • Multicenter Osteoarthritis Study (MOST)
  • Baseline fasting serum samples
  • Adjusted regression models

Main finding

Incident symptomatic knee OA

Odds ratio

1.0

95% CI 0.87–1.17

Per SD increase in EPA
OR 1.0 (95% CI 0.87–1.17)

Per SD increase in EPA, as printed

As reported in the abstract

Observational data: associations, not effects.

Further findings

Other OA outcomes (worsening MRI cartilage damage and synovitis, worsening knee pain, hand nodules)

Failed to suggest a protective effect of specific n-3 fatty acids

Original publication

Essential Fatty Acids and Osteoarthritis. Arthritis Care Res (Hoboken). Published 14 February 2024. doi:10.1002/acr.25302

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.